• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Penumbra

Penumbra launches Ruby XL coil system for large vessel embolization

June 9, 2025 By Danielle Kirsh

Penumbra (NYSE:PEN) has received FDA clearance and launched its Ruby XL system for embolization procedures. The Alameda, California-based device maker launched the platform as a new option for physicians treating high-flow or large-vessel cases. The Ruby XL system includes three new coils that are compatible with 0.035-inch diagnostic catheters and offer coils up to 40 mm […]

Filed Under: Cardiovascular Tagged With: Penumbra

Penumbra has positive data for computer-assisted vacuum thrombectomy system

November 5, 2024 By Sean Whooley

Penumbra (NYSE:PEN) today announced new data demonstrating improved outcomes with its computer-assisted vacuum thrombectomy (CAVT) technology. Data evaluated the use of the CAVT technology in people with intermediate-risk pulmonary embolism (PE). Results showed that those treated with CAVT had shorter hospital stay lengths, shorter post-procedure stay length and fewer complications when compared to other treatment […]

Filed Under: Catheters, Clinical Trials, Health Technology, Vascular Tagged With: ambulatory surgery centers (ASCs), Penumbra, Penumbra Inc.

Penumbra wins CE mark for computer-assisted thrombectomy tech

September 16, 2024 By Sean Whooley

Penumbra (NYSE:PEN) announced today that it received CE mark approval for its computer-assisted vacuum thrombectomy (CAVT) technologies. The Lightning Flash 2.0 and Lightning Bolt 7 offerings from the Alameda, California-based company both picked up European approval. Penumbra said approval makes its Lightning products the only CAVT systems available in Europe. The company’s latest offerings set […]

Filed Under: Catheters, Health Technology, Neurological, Regulatory/Compliance, Software / IT, Vascular Tagged With: Penumbra, Penumbra Inc.

Penumbra announces $200M share repurchase program

August 13, 2024 By Sean Whooley

Penumbra (NYSE:PEN) announced today that its board of directors approved a share repurchase authorization of up to $200 million. Alameda, California-based Penumbra said in a news release that its board approved the repurchase on Aug. 5. It allows the company to repurchase its common stock from time to time at such prices as it deems […]

Filed Under: Business/Financial News, Catheters, Funding Roundup, Neurological, Vascular Tagged With: Penumbra

Penumbra launches duo of stroke catheters in Europe

June 17, 2024 By Sean Whooley

Penumbra (NYSE:PEN) announced today that, with CE mark approval, it launched its new BMX81 and BMX96 neuro access devices in Europe. The company designed the devices for the neurovascular management of ischemic and hemorrhagic stroke. Penumbra said they represent its “most advanced neuro access offerings,” according to a news release. The launch further expands the […]

Filed Under: Catheters, Neurological, Regulatory/Compliance, Vascular Tagged With: Penumbra

FDA clears computer-assisted thrombectomy system from Penumbra

April 23, 2024 By Sean Whooley

Penumbra (NYSE:PEN) announced today that it received FDA clearance for and began the launch of its Lightning Flash 2.0 CAVT system. Lightning Flash 2.0 represents the next generation of the company’s computer-assisted vacuum thrombectomy (CAVT) technology. It removes the venous thrombus to treat pulmonary emboli (PE). The system features Lightning Flash algorithms designed for increased […]

Filed Under: 510(k), Business/Financial News, Catheters, Featured, Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Vascular Tagged With: Penumbra, Penumbra Inc.

First patient enrolled in Penumbra study of computer-assisted vacuum thrombectomy

November 28, 2023 By Sean Whooley

Penumbra (NYSE:PEN) today announced the first patient enrolled in STORM-PE, a trial of its Lightning Flash thrombectomy system. Lightning Flash, a mechanical thrombectomy system, received FDA clearance in January. The system features Penumbra’s novel Lightning intelligent aspiration technology with dual-clot detection algorithms. Combining it with innovative catheter engineering, Penumbra designed Lightning Flash to quickly remove […]

Filed Under: Clinical Trials, Featured, Health Technology, News Well, Vascular Tagged With: Penumbra

Penumbra, Veterans Health Administration expand access to rehab with VR

April 4, 2023 By Sean Whooley

Penumbra (NYSE:PEN) today announced a collaboration with the Veterans Health Administration (VHA) Office of Healthcare Innovation and Learning (OHIL). The collaboration covers testing, co-developing and implementing rehabilitative healthcare solutions through virtual reality (VR). Building on Penumbra’s REAL y-Series technology, the collaboration focuses on developing targeted therapy tools. These tools address the most critical rehabilitation needs […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, Software / IT Tagged With: Penumbra

Penumbra grows sales 8% in Q4

February 24, 2023 By Danielle Kirsh

Penumbra (NYSE:PEN) this week posted fourth-quarter results that beat the overall consensus on Wall Street. The Alameda, California-based company — maker of interventional devices for vascular and neuro therapies — reported profits of $3.9 million, or 10¢ per share, on sales of $221.2 million, for the three months ended Dec. 31, 2022. Sales were up 8.43% […]

Filed Under: Business/Financial News, Catheters, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Penumbra

FDA clears Lightning Flash thrombectomy system from Penumbra

January 10, 2023 By Sean Whooley

Penumbra (NYSE:PEN) announced today that it received FDA clearance for the Lightning Flash mechanical thrombectomy system. Alameda, California-based Penumbra also initiated the launch for the system. The company called Lightning Flash “the most advanced and powerful mechanical thrombectomy system on the market.” Lightning Flash features the company’s novel Lightning intelligent aspiration technology with dual-clot detection […]

Filed Under: Business/Financial News, Catheters, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: FDA, Penumbra

Penumbra launches VR-based rehab platform

November 15, 2022 By Sean Whooley

Penumbra (NYSE:PEN) announced today that it launched a full-body, non-tethered immersive healthcare offering for rehabilitation. Alameda, California–based Penumbra designed its REAL y-Series product with lower and upper body sensors. They allow clinicians to track full-body movement and progress in real-time. By expanding its virtual reality-based immersive healthcare platform, Penumbra plans to support a broad range […]

Filed Under: Business/Financial News, Featured, Health Technology, Neurological, News Well, Software / IT Tagged With: Penumbra

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy